Zarnegar-Lumley S, Pommert L, Lacayo NJ, Petit A, Shukla N, Stevens A, Gibson A, Tarlock K. Real-world experience with IDH inhibitors in pediatric patients with IDH1- and IDH2-mutated acute myeloid leukemia and myelodysplastic syndrome. Haematologica; https://doi.org/10.3324/haematol.2026.301245 [Early view].